<DOC>
	<DOCNO>NCT00083915</DOCNO>
	<brief_summary>The purpose study find transplant new regimen chemotherapy call DT PACE-Melphalan well transplant Melphalan alone . Another purpose study find few side effect new regimen DT PACE-Melphalan , compare melphalan alone .</brief_summary>
	<brief_title>DTPACE Followed Tandem Transplant With MEL 200 Versus MEL/DTPACE Hybrid DTPACE Consolidation</brief_title>
	<detailed_description>To evaluate , randomized phase III clinical trial previously treat multiple myeloma patient , whether angio-chemotherapy D.T . PACE follow tandem transplant MEL-DTPACE Hybrid may equivalent superior tandem transplant high dose melphalan term CR/near CR/VGPR rate event-free overall survival .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patients must active multiple myeloma require treatment . Patients receive &gt; 450 mg/m2 prior Adriamycin therapy eligible , however , Adriamycin delete DT PACE regimen patient , unless leave ventricular ejection fraction &gt; 55 % MUGA Scan ECHO . If patient &gt; 450 mg/m2 prior adriamycin , LVEF must evaluate prior every cycle DT PACE must &gt; 55 % patient continue receive adriamycin . All necessary baseline study determine eligibility must obtain within 35 day prior registration . Patients must performance status 02 base SWOG criterion . Patients poor performance status ( 34 ) , base solely bone pain , eligible . Patients must platelet count great equal 100,000/microliters . Patients platelet count &lt; 100,000/microliters may enrol felt due extensive marrow plasmacytosis . Patients must creatinine &lt; 3 mg/dl creatinine clearance great equal 30 ml/minute . Patients creatinine clearance 3050 ml receive 50 % cisplatin dose . Patients must adequate hepatic function define serum transaminase &lt; 2 x ULN direct bilirubin &lt; 2.0 mg/dl . Patients must able receive full dos DT PACE , opinion treat investigator , exception : Patients receive prior adriamycin &gt; 450 mg/m2 LVEF &lt; 55 % patient creatinine clearance 30 50 ml/minute , receive 50 % cisplatin dose . All patient must inform investigational nature study must sign give write informed consent accordance institutional federal guideline . Patients must significant comorbid medical condition uncontrolled life threaten infection . Patients must receive prior autotransplant allograft . Patients recent ( less equal 6 month ) myocardial infarction , unstable angina , difficult control congestive heart failure , uncontrolled hypertension , difficult control cardiac arrythmias ineligible . Ejection fraction ECHO must great equal 50 % must perform within 60 day prior registration , unless patient receive chemotherapy within period time ( dexamethasone thalidomide exclude ) , case LVEF must repeat . Patients must history chronic obstructive chronic restrictive pulmonary disease . No prior malignancy allow except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , cancer patient disease free least three years.Prior malignancy acceptable provide evidence disease within threeyear interval . Pregnant nursing woman may participate . Patients must significant comorbid medical condition uncontrolled life threaten infection . Patients must history chronic obstructive chronic restrictive pulmonary disease . Patients must adequate pulmonary function study great equal 50 % predict mechanical aspect ( FEV1 , FVC , etc ) diffusion capacity ( DLCO ) great equal 50 % predict . Patients unable complete pulmonary function test due myeloma related pain fracture must high resolution CT scan chest must also acceptable arterial blood gas define P02 great 70 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>DTPACE</keyword>
	<keyword>Tandem Transplant</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Etoposide</keyword>
	<keyword>Sargramostim</keyword>
	<keyword>Thalidomide</keyword>
	<keyword>Melphalan</keyword>
</DOC>